{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:06:24Z","timestamp":1791187584545,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1016,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1002\/hep.25897","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T15:28:39Z","timestamp":1340033319000},"page":"2060-2070","source":"Crossref","is-referenced-by-count":121,"title":["IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection"],"prefix":"10.1097","volume":"56","author":[{"given":"Heiyoung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Serti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyinyechi","family":"Eke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Muchmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Prokunina-Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Capone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Folgori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Rehermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2012,11,19]]},"reference":[{"key":"10.1002\/hep.25897-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence","volume":"119","author":"Rehermann","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1002\/hep.25897-BIB2|cit2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrgastro.2010.219","article-title":"Hepatitis in 2010: the dawn of a new era in HCV therapy","volume":"8","author":"Ciesek","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1002\/hep.25897-BIB3|cit3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1002\/hep.25897-BIB4|cit4","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1128\/JVI.75.15.7059-7066.2001","article-title":"DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection","volume":"75","author":"Bigger","year":"2001","journal-title":"J Virol"},{"key":"10.1002\/hep.25897-BIB5|cit5","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/hep.25897-BIB6|cit6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/jir.2009.0063","article-title":"Intracellular innate immune cascades and interferon defenses that control hepatitis C virus","volume":"29","author":"Horner","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"10.1002\/hep.25897-BIB7|cit7","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1073\/pnas.1002301107","article-title":"Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection","volume":"107","author":"Takahashi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/hep.25897-BIB8|cit8","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","article-title":"Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo","volume":"80","author":"Ank","year":"2006","journal-title":"J Virol"},{"key":"10.1002\/hep.25897-BIB9|cit9","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.02438-06","article-title":"Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases","volume":"81","author":"Zhou","year":"2007","journal-title":"J Virol"},{"key":"10.1002\/hep.25897-BIB10|cit10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1002\/hep.25897-BIB11|cit11","doi-asserted-by":"crossref","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1002\/hep.25897-BIB12|cit12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1002\/hep.25897-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1002\/hep.25897-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1002\/hep.25897-BIB15|cit15","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1002\/hep.25897-BIB16|cit16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2010.08.020","article-title":"Interferon-lambda serum levels in hepatitis C","volume":"54","author":"Langhans","year":"2011","journal-title":"J Hepatol"},{"key":"10.1002\/hep.25897-BIB17|cit17","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","article-title":"Lambda interferon inhibits hepatitis B and C virus replication","volume":"79","author":"Robek","year":"2005","journal-title":"J Virol"},{"key":"10.1002\/hep.25897-BIB18|cit18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jhep.2010.11.019","article-title":"IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway","volume":"55","author":"Zhang","year":"2011","journal-title":"J Hepatol"},{"key":"10.1002\/hep.25897-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"Marcello","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.25897-BIB20|cit20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nm1353","article-title":"A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees","volume":"12","author":"Folgori","year":"2006","journal-title":"Nat Med"},{"key":"10.1002\/hep.25897-BIB21|cit21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.gastro.2011.05.006","article-title":"Delayed induction, not impaired recruitment, of specific CD8 T cells causes the late onset of acute hepatitis C","volume":"141","author":"Shin","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.25897-BIB22|cit22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"10.1002\/hep.25897-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1053\/j.gastro.2008.12.034","article-title":"Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model","volume":"136","author":"Jo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.25897-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.4049\/jimmunol.174.4.1932","article-title":"IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29","volume":"174","author":"Siren","year":"2005","journal-title":"J Immunol"},{"key":"10.1002\/hep.25897-BIB25|cit25","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.4049\/jimmunol.179.6.3434","article-title":"IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes","volume":"179","author":"Osterlund","year":"2007","journal-title":"J Immunol"},{"key":"10.1002\/hep.25897-BIB26|cit26","doi-asserted-by":"crossref","first-page":"11564","DOI":"10.1073\/pnas.0904477106","article-title":"The role of transposable elements in the regulation of IFN-lambda1 gene expression","volume":"106","author":"Thomson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/hep.25897-BIB27|cit27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/jir.2010.0063","article-title":"Mechanisms of type III interferon expression","volume":"30","author":"Iversen","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"10.1002\/hep.25897-BIB28|cit28","doi-asserted-by":"crossref","DOI":"10.1002\/hep.24580","article-title":"Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures","author":"Marukian","year":"2011","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.25897-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2006.08.043","article-title":"Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection","volume":"131","author":"Randall","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.25897-BIB30|cit30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1099\/vir.0.015388-0","article-title":"ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment","volume":"91","author":"Chen","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1002\/hep.25897-BIB31|cit31","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.4049\/jimmunol.0900867","article-title":"Long double-stranded RNA induces an antiviral response independent of IFN regulatory factor 3, IFN-beta promoter stimulator 1, and IFN","volume":"183","author":"DeWitte-Orr","year":"2009","journal-title":"J Immunol"},{"key":"10.1002\/hep.25897-BIB32|cit32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"Honda","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.25897","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/hep.25897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T12:43:50Z","timestamp":1673441030000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hep.25897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,19]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.25897","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11,19]]}}}